We searched PubMed for full-text original studies and review articles written in English from Jan 1, 1990, to Nov 3, 2015, to identify reports about anthropometrics, morbidity, and mortality. We used the search terms “adult height”, “attained height”, “trends in height”, “growth patterns”, “insulin sensitivity”, “insulin resistance”, “nutrition”, “cardiovascular disease”, “diabetes”, “cancer”, and “mortality”. We used the reference lists of identified papers to identify further papers of
Personal ViewDivergent associations of height with cardiometabolic disease and cancer: epidemiology, pathophysiology, and global implications
Introduction
Cardiovascular disease, type 2 diabetes, and cancer are among the most important causes of morbidity and mortality worldwide.1, 2 An increase in total and abdominal fat mass in the general population is now accepted as a causative factor in the rising incidence of these diseases.3 Although BMI and waist circumference are established variables with which to assess morbidity and mortality risk, adult height also predicts mortality independently of adiposity measures.4 The recent increase in average adult height in many countries leads to the question of whether this secular trend in height might be a marker of a poorly understood physiological mechanism that affects not only stature but also development of cardiometabolic disease and incidence of cancer. In addition to being genetically determined, adult height is a marker for exposures affecting childhood growth (eg, maternal diet during pregnancy, childhood diet, infection, and psychological stress), which are thought to affect health during adulthood.5 Therefore, investigation of the complex epidemiology, biology, and pathophysiology related to attained height might improve our understanding of the height-associated mechanisms underlying cardiovascular disease, type 2 diabetes, and cancer, and might also have clinical and public health implications for present and future generations.
Section snippets
Secular trends in adult height in different populations
Height is a trait that has fascinated researchers for centuries. Height is the most noticeable and recognisable variable in human anthropometrics, and is widely used for diagnostic and therapeutic purposes. In utero, height measurements provide an estimate of fetal development, and in early childhood and puberty, it is widely used to estimate nutritional and hormonal status. Height is also used in calculations of fat mass and body surface area during adolescence and adulthood, enabling
Height and cause-specific mortality
The increasing prevalence of obesity contributes to the rising incidence of cardiometabolic diseases, and also to some types of cancer.1, 16 Increased BMI and waist circumference (estimates of total and visceral fat mass) are associated with higher non-communicable-disease-related mortality,17, 18 and the higher prevalence of total and upper-body fat mass in the general population is now accepted as a causative factor in the increasing incidence of these diseases.3 BMI and waist circumference
Increased height and reduced cardiometabolic risk
Although the inverse association between height and cardiometabolic risk is convincingly supported, the underlying mechanisms are mostly unknown. Because taller people tend to have stronger pulmonary function,38 differences in lung function might explain the link between increased height and reduced risk of cardiovascular disease.54 Additionally, taller people generally have lower blood cholesterol concentrations and systolic blood pressure7, 38 compared with shorter people. Taller people also
Association of macronutrient intake with growth and cancer incidence
Research into macronutrient intake might prove relevant for cancer incidence and cancer mortality. High intake of animal protein between ages 50 years and 65 years was associated with a four-times increased risk of cancer death in the NHANES III cohort.89 In that study, the association of protein intake with risk was stronger at higher serum IGF1 concentrations, although IGF1 itself did not explain the protein–cancer association. Animal data from that study suggested that protein intake might
Clinical implications of growth patterns and attained height
Although increased height is associated with reduced risk of cardiometabolic diseases and increased risk of several types of cancer, tallness is unlikely to modulate these diseases directly. Although mendelian randomisation studies have provided strong support for the divergent associations of height with cardiometabolic diseases and cancer, they have also linked several traits to height-related genetic variants. These traits might mediate the causal link between height and lower
Conclusions
The scientific community is increasingly interested in understanding the complex epidemiology and pathophysiology related to height. However, the basic mechanisms underlying the causes and medical effects of height are just beginning to be understood. Although adult height continues to increase, prevalence of obesity has also increased in most populations, which would be expected to mitigate height-associated reductions in risk of cardiometabolic disease. Moreover, the combination of increased
Search strategy and selection criteria
References (119)
- et al.
Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA
Lancet
(2014) - et al.
Long run trends in the heights of European men, 19th–20th centuries
Econ Hum Biol
(2010) - et al.
The role of nutrition and genetics as key determinants of the positive height trend
Econ Hum Biol
(2014) - et al.
Adult height and cancer mortality in Asia: the Asia Pacific Cohort Studies Collaboration
Ann Oncol
(2010) - et al.
Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk
Lancet Oncol
(2011) - et al.
Associations of mortality with own height using son's height as an instrumental variable
Econ Hum Biol
(2013) - et al.
The height of choosiness: mutual mate choice for stature results in suboptimal pair formation for both sexes
Anim Behav
(2013) - et al.
The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature
Chest
(2005) - et al.
Higher prevalence and greater severity of coronary disease in short versus tall men referred for coronary arteriography
Am Heart J
(1997) - et al.
Circulating concentrations of insulin-like growth factor-I and risk of breast cancer
Lancet
(1998)
Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf expression
Cell
The Lin28/let-7 axis regulates glucose metabolism
Cell
How does Lin28 let-7 control development and disease?
Trends Cell Biol
Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population
Cell Metab
Meta-analysis of animal fat or animal protein intake and colorectal cancer
Am J Clin Nutr
Association of diet with serum insulin-like growth factor I in middle-aged and elderly men
Am J Clin Nutr
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
Lancet
Abdominal obesity and metabolic syndrome
Nature
Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis
Int J Epidemiol
Associations of height, leg length, and lung function with cardiovascular risk factors in the Midspan Family Study
J Epidemiol Community Health
Risk factors for vertebral and nonvertebral fracture over 10 years: a population-based study in women
J Bone Miner Res
Assumption-free estimation of heritability from genome-wide identity-by-descent sharing between full siblings
PLoS Genet
New loci associated with birth weight identify genetic links between intrauterine growth and adult height and metabolism
Nat Genet
Defining the role of common variation in the genomic and biological architecture of adult human height
Nat Genet
The mysterious trend in American heights in the 20th century
Ann Hum Biol
Secular changes of stature in rural children and adolescents in China, 1985–2010
Biomed Environ Sci
Secular changes in stature and body mass index for Chinese youth in sixteen major cities, 1950s–2005
Am J Hum Biol
Secular trends in height in different states of India in relation to socioeconomic characteristics and dietary intakes
Food Nutr Bull
Noncommunicable diseases
N Engl J Med
Adiposity as compared with physical activity in predicting mortality among women
N Engl J Med
General and abdominal adiposity and risk of death in Europe
N Engl J Med
Competing risk regression models for epidemiologic data
Am J Epidemiol
Applying Cox regression to competing risks
Biometrics
Risk factors for mortality in the nurses' health study: a competing risks analysis
Am J Epidemiol
Height loss in older men—associations with total mortality and incidence of cardiovascular disease
Arch Intern Med
Short stature is associated with coronary heart disease: a systematic review of the literature and a meta-analysis
Eur Heart J
Adult height and risk of ischemic heart disease, atrial fibrillation, stroke, venous thromboembolism, and premature death: a population based 36-year follow-up study
Eur J Epidemiol
Adult height and the risks of cardiovascular disease and major causes of death in the Asia-Pacific region: 21,000 deaths in 510,000 men and women
Int J Epidemiol
Height in young adulthood and risk of death from cardiorespiratory disease: a prospective study of male former students of Glasgow University, Scotland
Am J Epidemiol
Hip circumference, height and risk of type 2 diabetes: systematic review and meta-analysis
Obes Rev
Height and pancreatic cancer risk: a systematic review and meta-analysis of cohort studies
Cancer Causes Control
Height and kidney cancer risk: a meta-analysis of prospective studies
J Cancer Res Clin Oncol
Height and prostate cancer risk: a large nested case-control study (ProtecT) and meta-analysis
Cancer Epidemiol Biomarkers Prev
Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors
PLoS Genet
Height and breast cancer risk: evidence from prospective studies and Mendelian randomization
J Natl Cancer Inst
Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results
J Natl Cancer Inst
Genetically determined height and coronary artery disease
N Engl J Med
Adult height, coronary heart disease and stroke: a multi-locus Mendelian randomization meta-analysis
Int J Epidemiol
Mendelian randomization study of height and risk of colorectal cancer
Int J Epidemiol
The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium
Cancer Causes Control
Cited by (85)
A global view of the interplay between non-alcoholic fatty liver disease and diabetes
2022, The Lancet Diabetes and EndocrinologyCitation Excerpt :However, due to a rapid global nutrition transition, many people are exposed to different forms of malnutrition during their life course and can be confronted with the double burden of malnutrition. This term refers to the observation that often malnutrition can occur during pregnancy, epigenetically inhibiting adequate insulin and IGF-1 signalling throughout the life of the child.86,87 This prenatal malnutrition is often associated with impaired glucose metabolism and short adult height in later life.87
Body surface area may explain sex differences in findings from the oral glucose tolerance test among subjects with normal glucose tolerance
2021, Nutrition, Metabolism and Cardiovascular DiseasesCitation Excerpt :It has also been postulated that shorter body height may explain the higher 2-h post-load plasma glucose (2hPG) concentrations in women [6–10]. The determinants of adult height and the association of height and development of T2D and cardiovascular disease (CVD) are just beginning to be understood [11]. When BMI or WC is used as a surrogate measure of body adiposity in clinical practice and in research settings, the effect of body height is diminished or dismissed.
Maternal height, gestational diabetes mellitus and pregnancy complications
2021, Diabetes Research and Clinical PracticeMulti-Trait Body Shape Phenotypes and Breast Cancer Risk in Postmenopausal Women: A Causal Mediation Analysis in the UK Biobank Cohort
2024, Journal of Epidemiology and Global Health